{"brief_title": "The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients", "brief_summary": "To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts <= 100 cells/mm3.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Clarithromycin", "criteria": "Inclusion Criteria Patients must have: - HIV infection. - CD4 count <= 100 cells/mm3. - No evidence of MAC. - Life expectancy of at least 6 months. Exclusion Criteria Concurrent Medication: Excluded: - Certain restricted drugs (details not available). Patients with the following prior conditions are excluded: History of allergy or hypersensitivity to macrolides. Active substance abuse or other conditions that would affect study compliance.", "gender": "All", "minimum_age": "12 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00002336.xml"}